Latest Organofluorides Stories
TAIPEI, April 27, 2015 /PRNewswire/ -- TWi Pharmaceuticals, Inc.
NORTHBROOK, Ill., April 23, 2015 /PRNewswire/ -- Astellas announced today that seven abstracts will be presented on CRESEMBA® (isavuconazonium sulfate), the prodrug for isavuconazole, at the 25th
Updated clinical data presented in an oral session at the 2015 American Association for Cancer Research Annual Meeting CAMBRIDGE, Mass., April 21, 2015 /PRNewswire/ -- Merrimack Pharmaceuticals,
- Note: This press release corresponds to abstract 396 PHILADELPHIA, April 20, 2015 /PRNewswire/ -- Ibrutinib (IMBRUVICA(®)) data presented yesterday by Pharmacyclics, Inc.
Diverse pipeline compounds target key cancer pathways INDIANAPOLIS, April 20, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present early stage data from several targeted
Designation would provide study protocol assistance and market exclusivity PETACH TIKVA, Israel, April 20, 2015 /PRNewswire/ -- Can-Fite
GENEVA, April 17, 2015 /PRNewswire/ -- ASSESS shows plasma circulating tumour DNA (ctDNA) testing for EGFR mutation is a viable alternative
Non-invasive liquid biopsy enables detection of emerging T790M mutations with greater sensitivity than tissue biopsy and months before detection of cancer progression with imaging
ADELAIDE, Australia, April 17, 2015 /PRNewswire/ -- Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused on the discovery and development of innovative therapeutics for
Trial is the first to study schizophrenia treatment within the context of many real-world issues faced by patients with schizophrenia TITUSVILLE, N.J., April 15, 2015 /PRNewswire/ -- A study
- A serpent whose bite was fabled to produce intense thirst.